James Quigley
Stock Analyst at Goldman Sachs
(0.23)
# 4,602
Out of 5,065 analysts
296
Total ratings
40%
Success rate
-6.9%
Average return
Main Sectors:
Stocks Rated by James Quigley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SWX: LONN Lonza Group AG | Reiterated: Buy | CHF 680.00 | CHF 613.20 | +10.89% | 23 | Oct 1, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Reiterated: Hold | €190.00 → €244.00 | €260.40 | -6.30% | 32 | Oct 1, 2026 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Reiterated: Buy | €214.00 → €223.00 | €211.80 | +5.29% | 24 | Oct 1, 2026 | |
| SWX: NOVN Novartis AG | Reiterated: Sell | CHF 110.00 | CHF 124.20 | -11.43% | 29 | Sep 30, 2026 | |
| SWX: ROP Roche Holding AG | Reiterated: Hold | CHF 348.00 → CHF 366.00 | CHF 380.10 | -3.71% | 27 | Sep 15, 2026 | |
| NVO Novo Nordisk | Reiterated: Hold | $47 → $44 | $38.42 | +14.52% | 10 | Aug 6, 2026 | |
| ETR: BAYN Bayer Aktiengesellschaft | Reiterated: Buy | €62.50 → €63.50 | €43.40 | +46.31% | 61 | Aug 5, 2026 | |
| EPA: SAN Sanofi | Reiterated: Hold | €89.00 → €84.00 | €71.01 | +18.29% | 10 | Jul 6, 2026 | |
| ETR: MRK Merck KGaA | Reiterated: Buy | €153.00 → €147.00 | €144.35 | +1.84% | 43 | Apr 16, 2026 | |
| RHHBY Roche Holding AG | Upgraded: Hold | n/a | $57.14 | - | 1 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $121 → $118 | $150.20 | n/a | 3 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $898.50 | n/a | 1 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $65 → $60 | $39.57 | n/a | 2 | Jul 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | 15,200p | 12,400p | n/a | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €13.00 → €10.50 | €0.76 | n/a | 2 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | CHF 65.00 → CHF 64.00 | CHF 83.50 | n/a | 2 | Sep 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 38.00 → CHF 21.00 | CHF 44.05 | n/a | 5 | Sep 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €27.00 → €28.00 | €2.63 | n/a | 10 | Sep 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €38.00 → €36.00 | €26.46 | n/a | 2 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $15 | $1.43 | n/a | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $140 → $205 | $29.79 | n/a | 2 | Jan 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $38.50 | n/a | 1 | Jun 20, 2018 |
Lonza Group AG
Oct 1, 2026
Reiterated: Buy
Price Target: CHF 680.00
Current: CHF 613.20
Upside: +10.89%
Sartorius Aktiengesellschaft
Oct 1, 2026
Reiterated: Hold
Price Target: €190.00 → €244.00
Current: €260.40
Upside: -6.30%
Sartorius Stedim Biotech S.A.
Oct 1, 2026
Reiterated: Buy
Price Target: €214.00 → €223.00
Current: €211.80
Upside: +5.29%
Novartis AG
Sep 30, 2026
Reiterated: Sell
Price Target: CHF 110.00
Current: CHF 124.20
Upside: -11.43%
Roche Holding AG
Sep 15, 2026
Reiterated: Hold
Price Target: CHF 348.00 → CHF 366.00
Current: CHF 380.10
Upside: -3.71%
Novo Nordisk
Aug 6, 2026
Reiterated: Hold
Price Target: $47 → $44
Current: $38.42
Upside: +14.52%
Bayer Aktiengesellschaft
Aug 5, 2026
Reiterated: Buy
Price Target: €62.50 → €63.50
Current: €43.40
Upside: +46.31%
Sanofi
Jul 6, 2026
Reiterated: Hold
Price Target: €89.00 → €84.00
Current: €71.01
Upside: +18.29%
Merck KGaA
Apr 16, 2026
Reiterated: Buy
Price Target: €153.00 → €147.00
Current: €144.35
Upside: +1.84%
Roche Holding AG
Jan 15, 2026
Upgraded: Hold
Price Target: n/a
Current: $57.14
Upside: -
Sep 12, 2025
Downgraded: Sell
Price Target: $121 → $118
Current: $150.20
Upside: n/a
Jul 30, 2025
Reiterated: Hold
Price Target: n/a
Current: $898.50
Upside: n/a
Jul 3, 2025
Reiterated: Hold
Price Target: $65 → $60
Current: $39.57
Upside: n/a
May 30, 2024
Initiated Coverage: Buy
Price Target: 15,200p
Current: 12,400p
Upside: n/a
Oct 10, 2023
Reiterated: Hold
Price Target: €13.00 → €10.50
Current: €0.76
Upside: n/a
Sep 25, 2023
Reiterated: Sell
Price Target: CHF 65.00 → CHF 64.00
Current: CHF 83.50
Upside: n/a
Sep 25, 2023
Reiterated: Hold
Price Target: CHF 38.00 → CHF 21.00
Current: CHF 44.05
Upside: n/a
Sep 25, 2023
Reiterated: Buy
Price Target: €27.00 → €28.00
Current: €2.63
Upside: n/a
Sep 5, 2023
Reiterated: Hold
Price Target: €38.00 → €36.00
Current: €26.46
Upside: n/a
Aug 8, 2023
Reiterated: Buy
Price Target: $16 → $15
Current: $1.43
Upside: n/a
Jan 5, 2020
Downgraded: Hold
Price Target: $140 → $205
Current: $29.79
Upside: n/a
Jun 20, 2018
Upgraded: Buy
Price Target: n/a
Current: $38.50
Upside: n/a